Sugammadex Hypersensitivity Study (Study P06042)

Status Completed

Clinical Trial Summary

This trial was conducted to study the potential for hypersensitivity symptoms at the time of initial exposure to sugammadex and upon repeat exposure, since it was unknown whether the frequency or severity of hypersensitivity symptoms may worsen at repeat exposure over a prolonged period.

In total 450 participants (all healthy subjects) were to be randomized to receive one of three study treatments: three repeated doses of either sugammadex 4 mg/kg, sugammadex 16 mg/kg, or placebo. Participants were to receive one dose of study treatment on Day 8, Day 36, and Day 78 of the study in order to determine the safety of each treatment dose.

Clinical Trial Description

All subjects were to be admitted to the study center the day before each scheduled dose and were to leave the unit the morning of the day after each dose. In cases of suspected hypersensitivity symptoms, healthy subjects were to remain confined to the study center until all signs and symptoms regressed, the subject was stable, and the investigator considered it safe for the subject to leave the study center. Four sites participated in this trial. ;

Study Design

Related Conditions & MeSH terms

Hypersensitivity

Clinical Trial Details

NCT number	NCT00988065
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 1
Start date	September 6, 2009
Completion date	April 13, 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04531540` - Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)	Phase 3
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Completed	`NCT02588326` - Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays	Phase 1
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02360072` - Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
Completed	`NCT02352168` - Airway Inflammation in Children With Allergic Rhinitis and Intervention	N/A
Completed	`NCT01904604` - Peanut Epicutaneous Phase II Immunotherapy Clinical Trial	Phase 2
Completed	`NCT01494649` - Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity	N/A
Enrolling by invitation	`NCT05039229` - Measures for Bioaerosol Reduction in the Salmon Industry	N/A
Enrolling by invitation	`NCT05675241` - Characterizing the Inflammation Around Dental Implants
Active, not recruiting	`NCT04006106` - Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
Not yet recruiting	`NCT06065137` - Standardised Drug Provocation Testing in Perioperative Hypersensitivity	Phase 4
Completed	`NCT04605471` - A Study to Learn More About the Safety of Ultravist in Children and in the Elderly
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Terminated	`NCT05247567` - Quaternary Ammonium and Immunization in Hairdressers	N/A
Completed	`NCT05119751` - Vestibular Versus Sublingual Route of AIT Tablets	Phase 4
Recruiting	`NCT05960266` - Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study	Early Phase 1
Not yet recruiting	`NCT04485299` - Clinical Assessment of Bifluorid 10 vs Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient	Phase 2/Phase 3
Completed	`NCT02686827` - DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.	Phase 2
Completed	`NCT00850668` - Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults	Phase 1